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Background: Procalcitonin, a precursor protein of the hormone calcitonin, is a sensitive marker 
for sepsis in human medicine, which is used for diagnosis of bacterial pneumonia in adults and 
neonates to initiate antibiotic therapy. Objectives: In this study, procalcitonin was evaluated as a 
potential biomarker for Rhodococcus equi associated pneumonia. Methods: In four foals procalci-
tonin was measured at four time-points (day 0 before antibiotic therapy, day 1, 3 and 5/6 during 
therapy) in plasma using an equine specific ELISA. Inclusion criteria for the study were a positive 
sepsis score, ultrasonographic evidence of pulmonary abscesses in addition >8 cm, a positive mi-
crobiology out of tracheobronchial secretion and positive response to antibiotic treatment (azith-
romycin 10 mg/kg BDW 24q PO and rifampicin 10 mg/kg BDW 12q PO) within a weak including 
improvement of clinical status and reduction of ultrasonographic score <8 cm. Results: Procalci-
tonin concentrations remained below the working range of the ELISA (25 - 1000 ng/ml) in all but 
one sample. Conclusions: Procalcitonin cannot be regarded a useful biomarker in pneumonia as-
sociated with Rhodococcus equi. 
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c-cells. Low concentrations of <0.1 ng/ml are found in human serum [1].  
Since the 1970s hypocalcemia has been studied in correlation to sepsis [2]. During sepsis, PCT is found in 
high concentrations in blood and almost all tissues [3]. It not only is a precursor of calcitonin leading to hypo-
calcemia, but also seems to have another pathophysiologic role as an inflammatory mediator and is found in al-
most all inflammatory processes independent from hypocalcemia. As PCT concentrations in plasma rise quick-
ly—within 3 hours after experimental sepsis induction by intravenous endotoxin PCT levels in men increase 
significantly—PCT has become a useful point-of-care parameter in intensive care units [4]. It has been shown 
that mortality increases by 7.6% with every hour of delayed treatment [5].   
In horses, and particular in foals, the gastrointestinal tract and the lung are common primarily affected organ 
systems in sepsis. In neonatal foals, sepsis is one of the main causes of death [6]. Diagnosis of sepsis by blood 
cultures takes 48 - 72 hours [7], which is too long to ensure survival in these foals.  
Pulmonary inflammation in men is associated with lower PCT concentrations compared to endotoxemia and 
sepsis, but differentiation between different forms of pneumonia is still possible [8]-[10]. For example, PCT has 
been used as a biomarker in the diagnosis of tuberculosis [11].  
Rhodococcosis, a pyogranulomatous pneumonia caused by the gram-positive saprophyte Rhodococcus equi, 
is a pulmonary disease with a high ecomic impact in foals worldwide [12] [13]. Recommended antibiotics, 
commonly a combination of rifampicin and a macrolide, are expensive drugs and duration of therapy is very 
long with 4 - 6 weeks, although it could be shown that number and size of abscesses clearly decrease within 1 - 
2 weeks under adequate therapy [14]. Regular ultrasonographic controls have been found most useful to check 
the success of therapy, while different blood parameters were unreliable including the white blood cell count and 
fibrinogen concentration [15] [16].  
In this study, we aimed to evaluate the biomarker procalcitonin for its usefulness as an early indicator of sep-
sis and to control treatment success in foals suffering from Rhodococcus equi associated pneumonia. Rieger et al. 
established a new species specific ELISA for equine PCT, which allows evaluating the actual PCT concentration 
and not only its gene expression with a high specifity and sensitivity [17]. We figured that this biomarker might 
allow reducing antibiotic treatment in the long term and shorten the duration of therapy in affected foals.  
2. Materials and Methods 
During a first disease outbreak of Rhodococcus equi associated pneumonia in a stud, which had been proven by 
repeated microbiologic examinations of tracheal aspirates, PCT concentrations were measured in 4 foals at dif-
ferent time-points in the course of the disease, beginning before the initiation of antibiotic therapy up to signifi-
cant clinical improvement.  
Overall, more than 20 foals were affected by respiratory disease, but inclusion criteria were strict including a 
modified positive sepsis score (≥10 points) according to Breuer et al. [18] at the beginning of sampling, an ul-
trasonographic abscess score >8 cm [14], positive microbiology for Rhodococcus equi and a first sample before 
the initiation of antibiotic therapy. In addition, only foals were included into the study, which showed a reduc-
tion in sepsis score and ultrasonographic score <8 cm within the first week of therapy.  
On day 0 clinical, ultrasonographic, endoscopic and laboratory examinations were performed to classify the 
foals according to a modified sepsis score [18] as shown in Table 1. This score was simplified by reducing clin-
ical pathology to WBC (white blood cells), while the percentage of neutrophils, thrombocyte count and concen-
tration of fibrinogen were not measured. According to the original score results ≥13 out of 41 points are classi-
fied as positive for sepsis, but as the maximum score in the modified version was 29 points, we reduced the in-
clusion border to 10 points for our study. The diameters of abscesses visible in ultrasonography of left and right 
thorax were added to account for the ultrasonographic score. Endoscopy was performed under sedation (xylazin 
0.6 - 1.0 mg/kg BDW IV). In all 4 foals high amounts of viscous mucopurulent secretions were evident in the 
trachea (Figure 1). Using capped catheter systems tracheal aspirate samples were taken for microbiologic cul-
tures. The jugular vein was punctuated to gain venous blood for clinical pathology (WBC, PCT). Plasma for 
PCT measurements was frozen at −20˚C and stored on dry ice during transport to the Helmholtz-Center in Mu-
nich, where PCT was measured using a species specific ELISA for equine PCT [17]. After first samples were 
taken, antibiotic therapy including azithromycin (10 mg/kg PO SID) and rifampicin (10 mg/kg PO BID) was in-
itiated.  
On day 1 after beginning of antibiotic treatment, on day 3 and after clinical improvement (day 5 - 6) clinical 
examinations were repeated and further venous blood samples taken for clinical pathology (WBC, PCT). Ultra- 




Figure 1. Mucopurulent secretion in the trachea of an affected foal. 
 
Table 1. Sepsis score, modified after Breuer et al. (2012).                                                        
Parameter 0 1 2 3 
General condition bright, alert mildly reduced moderately reduced severely reduced 
Heart rate/min 28 - 40 41 - 60 61 - 80 >80 
Respiratory rate/min 10 - 14 15 - 25 26 - 45 >45 
Temperature [˚C] 37.5 - 38.0 37.0 - 37.4 or 38.1 - 38.5 36.5 - 36.9 or 38.6 - 39.0 <36.5 or >39.0 
Petechialbleeding not found  found  
Diarrhoea not found  found  
Dyspnoe not found  found  
Wunden not found  found  
Pulsation none mild moderate severe 
Infection microbiology negative   microbiology positive 
WBC [G/l] 4.9 - 12.6 4.0 - 4.8 or 12.7 - 15.0 3.0 - 3.9 or 15.1 - 20.0 <3.0 or >20.0 
 
sonography was also repeated after clinical improvement.  
3. Results 
On day 0 all foals presented with lethargy, increased body temperature, dyspnea and leucocytosis. Sonography 
of the thorax revealed multiple hypoechogenic soft tissue masses interpreted as abscesses adding to a score of 10 
- 22 cm. The results of clinical, laboratory and sonographic examinations are shown in Table 2.  
Antibiotic therapy was initiated due to former microbiology positive for Rhodococcus equi from tracheal as-
pirates and pulmonary tissue, before the microbiologic results were available for the individual foal. In less than 
50% of affected foals Rhodococcus equi infection was confirmed by microbiology. In six foals cytology and 
microbiology revealed an infection with Streptococcus equi spp. zooepidemicus (Figure 2 & Figure 3). As this 
was interpreted as a possible secondary infection, the antibiotic therapy including azithromycin and rifampicin 
was continued. As already mentioned, only foals were included into the statistical analysis, for which Rhodo-
coccus equi infection was actually proven.  
After initiation of antibiotic therapy these 4 foals showed rapid improvement within 5 - 6 days including im-
provement of general condition and dyspnea. Nevertheless, all but one foal were still febrile. There was also a 
clear reduction in ultrasonography scores to 4 - 7 cm. In none of the foals a reduction of leukocytosis was evident.  




Figure 2. Sonographic appearance of a rough pleural surface, loss of 
reverberation artefacts, comet tail artefacts and a pulmonary abscess. 
The sum of abscess diameters accounted for the sonographic score, 
which was an inclusion criterion >8 cm for the study.                     
 
 
Figure 3. Multiple coccoid bacteria in chains in tracheal aspirate 
cytology. In several foals Streptococcus equi spp. zooepidemicus was 
found, probably as secondary infection.                              
 
PCT concentrations remained below the working range of the ELISA (25 - 1000 ng/ml) for the whole study pe-
riod apart from a single measurement (day 0 in foal No. 2).  
4. Discussion 
Biomarkers are used in human and veterinary medicine for several reasons. They may ease diagnosing disease 
early, support the decision for or against antibiotic use and to shorten the duration of antibiotic therapy.  
In the late 1990s, it has been shown that procalcitonin is a sensitive marker for systemic inflammatory 
processes caused by bacterial infection, but not of other pathogenesis [19]-[21]. The lung is the primary organ to 
be affected by Rhodococcus equi, but other organs and joints can be affected as well. Therefore, not only a local 
reaction, but a systemic inflammatory response is evident in many cases. The high clinical sepsis scores and 
white blood cell counts support the severity of infection on all 4 foals studied. Equine PCT was characterized in 
the early 2000s [22]. Hypocalcemia in case of acute systemic disease was also found in horse [23]. Low plasma 
levels of ionized calcium were found in severe colic, gastrointestinal inflammation and induced endotoxemia  
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Table 2. Results of clinical and laboratory examinations (sepsis score), thoracic sonography (sonography score) and 
evaluation of PCT concentration in plasma before (day 0) and under the course of antibiotic therapy (day 1, 3 and 5/6) in 4 
foals (No. 1 - 4).                                                                                            
No. Day Age [days] BDW [kg] Sepsis-Score Sonography-Score WBC [G/l] PCT [ng/ml] 
1 0 78 140 15 14 24.9 <24 
1 1   12  28.0 <24 
1 3   12  39.7 <24 
1 5/6   11 6 22.4 <24 
2 0 99 155 12 10 16.8 199 
2 1   10  16.6 <24 
2 3   9  16.7 <24 
2 5/6   9 4 15.2 <24 
3 0 106 165 14 10 14.0 <24 
3 1   10  15.7 <24 
3 3   8  16.1 <24 
3 5/6   9 7 16.0 <24 
4 0 86 120 14 22 17.1 <24 
4 1   10  17.0 <24 
4 3   8  16.1 <24 
4 5/6   10 6 18.0 <24 
 
[24] [25]. In foals, in which sepsis is one of the main causes of death in the neonatal period, hypocalcemia has 
also been correlated to the severity of disease [26]. On the other hand, Pusterla et al. [7] found no significant 
differences in mRNA expression for IL-1ß, IL-6 and PCT between healthy and septic foals. Nevertheless, the 
mean PCT expression was higher in septic foals compared to non-septic or healthy foals due to a higher varia-
tion of data in sepsis. The authors argued that PCT is not expressed by leucocytes to a high degree, while Tori-
bio [23] described the very complex composition of the CALC-I-gene and questioned the primer sequences in 
the PCR used. The species specific ELISA used in our study however has been found to have a high sensitivity 
even in horses, in which sepsis was questionable [17]. In a study on colic patients high concentrations were 
found using this ELISA as well [27]. Foals may be different, but horses at 3 month of age are not regarded as 
neonates anymore, and even in neonates, PCT is a valuable biomarker for EONS (early-onset neonatal sepsis) in 
intensive-care units in human medicine. As early as at 24 h of age PCT is more sensitive as c-reactive protein 
[28].  
5. Conclusion 
In conclusion, procalcitonin cannot be regarded a useful biomarker in pneumonia associated with Rhodococcus 
equi in the 4 foals of the age group studied. Nevertheless, further studies on a higher number of foals and sam-
ples may come to different results. 
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